Evidence map›Paper›PMID 40062433›Full record

ArticleAngewandte Chemie (International ed. in English)2025

Using Color to Control Conformation in a Chemical System Containing Multiple Tricyanofuran Photoacids.

Matthew M Wootten, Sofja Tshepelevitsh, Ivo Leito, Jonathan Clayden

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Matthew M WoottenSchool of Chemistry, University of Bristol, Cantock's Close, Bristol, BS8 1TS, UK.
Sofja TshepelevitshInstitute of Chemistry, University of Tartu, Ravila 14a, Tartu, 50411, Estonia.
Ivo LeitoInstitute of Chemistry, University of Tartu, Ravila 14a, Tartu, 50411, Estonia.
Jonathan ClaydenSchool of Chemistry, University of Bristol, Cantock's Close, Bristol, BS8 1TS, UK.

Funding

Engineering and Physical Sciences Research Council EP/P027067/1Estonian Research Council PRG690European Research Council 883786
6 · The paper itself

Abstract

Color vision relies on selective, reversible isomerization by visible light of a mixture of retinyl chromophores in photoreceptor cells. Synthetic molecular mimics of this wavelength-dependent induction of function are rare, despite the attractiveness of controlling chemical processes solely by the wavelength of incident light. Here, we report a color-responsive chemical system that is composed of a cationic receptor complex, two competing chiral anionic ligands, and two metastable photoacids with contrasting absorption properties. Tricyanofuran photoacids are synthesized with absorption maxima of varying wavelengths across the whole visible spectrum. Protons released by the photoacids upon selective irradiation reversibly mask the more basic receptor-bound ligand, leading to ligand exchange that can be observed as a shift in the circular dichroism (CD) spectrum of the reporter complex. A ≈90 nm separation between the absorbance maxima of the photoacids allowed each to be selectively photoisomerized in the presence of the other. The concentration of released protons, and hence the magnitude of the shift in CD response, are controlled by changing the wavelength of the incident visible light. Different output behaviors (OR/AND logic gates and wavelength detection) are programmed into the system by varying the relative proportions of the photoacids.

Indexed as

Circular dichroismOut‐of‐equilibrium systemsPhotoacidsReversible molecular logicWavelength selectivity

Identifiers

PMID40062433
PMCPMC12087846

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.